That trial is probably going to be worth a billion dollars when completed and the outcome is certain. They only need 20% efficacy. Calmare is usally around 80% effiay.How do biotech companies raise big money for phase 3 studies when they have no current profits? It's all about future expectations of revenues. We should have NO Problem raising the money.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.